Drug-related health and security threats in the Western Balkans are highlighted in a new report published by the EU drugs agency (EMCDDA). Released in the framework of the agency’s latest Instrument for Pre-accession Assistance project (IPA7), funded by the EU, the report provides the latest picture of the drug situation in the region.
The report offers a top-level analysis of drug markets, their drivers, facilitators and consequences, as well as an overview of drug policy and the law, drug use, harms and responses. It concludes with a regional overview of each of the major drug types, focusing on use, production and trafficking. Additional challenges, such as corruption, violence and the internationalisation of organised crime networks are also considered.
The findings are based on EMCDDA data collected through structured questionnaires and complemented by information from studies, focus groups and scientific literature. It appears that drug-related information is overall relatively limited in the region, although this varies, to some extent, between the partners concerned.